168 related articles for article (PubMed ID: 28434931)
1. Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting.
Tang J; Kuai R; Yuan W; Drake L; Moon JJ; Schwendeman A
Nanomedicine; 2017 Aug; 13(6):1869-1878. PubMed ID: 28434931
[TBL] [Abstract][Full Text] [Related]
2. Effect of Synthetic High Density Lipoproteins Modification with Polyethylene Glycol on Pharmacokinetics and Pharmacodynamics.
Li D; Fawaz MV; Morin EE; Ming R; Sviridov D; Tang J; Ackermann R; Olsen K; Remaley AT; Schwendeman A
Mol Pharm; 2018 Jan; 15(1):83-96. PubMed ID: 29141139
[TBL] [Abstract][Full Text] [Related]
3. Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy.
Gong M; Zhang Q; Zhao Q; Zheng J; Li Y; Wang S; Yuan Y
Drug Deliv; 2019 Dec; 26(1):708-716. PubMed ID: 31290708
[TBL] [Abstract][Full Text] [Related]
4. Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma.
Kuai R; Subramanian C; White PT; Timmermann BN; Moon JJ; Cohen MS; Schwendeman A
Int J Nanomedicine; 2017; 12():6581-6594. PubMed ID: 28919755
[TBL] [Abstract][Full Text] [Related]
5. Chemical conjugation mitigates immunotoxicity of chemotherapy via reducing receptor-mediated drug leakage from lipid nanoparticles.
Zheng C; Zhang W; Gong X; Xiong F; Jiang L; Zhou L; Zhang Y; Zhu HH; Wang H; Li Y; Zhang P
Sci Adv; 2024 Jun; 10(23):eadk9996. PubMed ID: 38838152
[TBL] [Abstract][Full Text] [Related]
6. Mimetic sHDL nanoparticles: A novel drug-delivery strategy to target triple-negative breast cancer.
Wang T; Subramanian C; Yu M; White PT; Kuai R; Sanchez J; Moon JJ; Timmermann BN; Schwendeman A; Cohen MS
Surgery; 2019 Dec; 166(6):1168-1175. PubMed ID: 31371177
[TBL] [Abstract][Full Text] [Related]
7. Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin.
Yuan Y; Wen J; Tang J; Kan Q; Ackermann R; Olsen K; Schwendeman A
Int J Nanomedicine; 2016; 11():6229-6238. PubMed ID: 27920529
[TBL] [Abstract][Full Text] [Related]
8. Synthetic high-density lipoprotein nanoparticles: A novel therapeutic strategy for adrenocortical carcinomas.
Subramanian C; Kuai R; Zhu Q; White P; Moon JJ; Schwendeman A; Cohen MS
Surgery; 2016 Jan; 159(1):284-94. PubMed ID: 26582501
[TBL] [Abstract][Full Text] [Related]
9. Characterization of apolipoprotein A-I peptide phospholipid interaction and its effect on HDL nanodisc assembly.
Patel H; Ding B; Ernst K; Shen L; Yuan W; Tang J; Drake LR; Kang J; Li Y; Chen Z; Schwendeman A
Int J Nanomedicine; 2019; 14():3069-3086. PubMed ID: 31118623
[No Abstract] [Full Text] [Related]
10. Phospholipid Component Defines Pharmacokinetic and Pharmacodynamic Properties of Synthetic High-Density Lipoproteins.
Fawaz MV; Kim SY; Li D; Ming R; Xia Z; Olsen K; Pogozheva ID; Tesmer JJG; Schwendeman A
J Pharmacol Exp Ther; 2020 Feb; 372(2):193-204. PubMed ID: 31776208
[TBL] [Abstract][Full Text] [Related]
11. Impact of PEGylated Nanoparticles on Tumor Targeted Drug Delivery.
Mozar FS; Chowdhury EH
Curr Pharm Des; 2018; 24(28):3283-3296. PubMed ID: 30062957
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
[TBL] [Abstract][Full Text] [Related]
13. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
[TBL] [Abstract][Full Text] [Related]
14. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
15. Synthetic high-density lipoprotein nanoparticles delivering rapamycin for the treatment of age-related macular degeneration.
Mei L; Yu M; Liu Y; Weh E; Pawar M; Li L; Besirli CG; Schwendeman AA
Nanomedicine; 2022 Aug; 44():102571. PubMed ID: 35623563
[TBL] [Abstract][Full Text] [Related]
16. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
Demirgöz D; Garg A; Kokkoli E
Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
[TBL] [Abstract][Full Text] [Related]
17. Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells.
Pozzi D; Colapicchioni V; Caracciolo G; Piovesana S; Capriotti AL; Palchetti S; De Grossi S; Riccioli A; Amenitsch H; Laganà A
Nanoscale; 2014 Mar; 6(5):2782-92. PubMed ID: 24463404
[TBL] [Abstract][Full Text] [Related]
18. Development of synthetic peptide-modified liposomes with LDL receptor targeting capacity and improved anticancer activity.
Liu M; Li W; Larregieu CA; Cheng M; Yan B; Chu T; Li H; Mao SJ
Mol Pharm; 2014 Jul; 11(7):2305-12. PubMed ID: 24830852
[TBL] [Abstract][Full Text] [Related]
19. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides.
Gomaraschi M; Calabresi L; Rossoni G; Iametti S; Franceschini G; Stonik JA; Remaley AT
J Pharmacol Exp Ther; 2008 Feb; 324(2):776-83. PubMed ID: 18042829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
